ETF Holdings Breakdown of SLRN

Stock NameACELYRIN, INC. Common Stock
TickerSLRN(USD) NASDAQ
TYPECommon Stock
CountryUSA

News associated with SLRN

Russell Investments Group Ltd. Decreases Stake in Acelyrin, Inc. (NASDAQ:SLRN)
Russell Investments Group Ltd. trimmed its position in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) by 12.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 66,699 shares of the company’s stock after selling 9,341 shares during the quarter. Russell Investments Group Ltd.’s holdings in Acelyrin were worth $209,000 as of its […] - 2025-04-25 07:50:47
JPMorgan Chase & Co. Reduces Holdings in Acelyrin, Inc. (NASDAQ:SLRN)
JPMorgan Chase & Co. decreased its holdings in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) by 27.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 618,127 shares of the company’s stock after selling 232,534 shares during the period. JPMorgan Chase & Co.’s holdings in Acelyrin were worth $1,941,000 at the end of […] - 2025-04-25 07:18:47
Wellington Management Group LLP Makes New Investment in Acelyrin, Inc. (NASDAQ:SLRN)
Wellington Management Group LLP bought a new position in Acelyrin, Inc. (NASDAQ:SLRN – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 180,539 shares of the company’s stock, valued at approximately $567,000. A number of other institutional investors have also […] - 2025-04-15 07:48:51

SLRN institutional holdings

The following institutional investment holdings of SLRN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 52,613USD 129,428
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 52,613USD 129,428 1.6%
Total =105,226 USD 258,856
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.